Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Castration-resistant Prostate Cancer Patients with Oligometastases × Radiosurgery × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Pain 1 Neoplasm Metastasis 1 NSCLC 1 Colorectal Neoplasms 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

luprolide acetate gel depot 1 enzalutamide 1 Triptorelin Pamoate 1 Radiosurgery 1 Leuprolide 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02685397 2024-12-04

PCS IX

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2/3 Active not recruiting

Castration-resistant Prostate Cancer Patients with Oligometastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡